{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:12:03Z","timestamp":1790118723789,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["35\/15\/10\/BMS\/NANO"],"award-info":[{"award-number":["35\/15\/10\/BMS\/NANO"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.msec.2017.02.145","type":"journal-article","created":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T07:01:11Z","timestamp":1488697271000},"page":"1465-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis"],"prefix":"10.1016","volume":"75","author":[{"given":"Rishikesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh C","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VNR","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RK","family":"Topno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2017.02.145_bb0005","series-title":"Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva","author":"Organization WH","year":"2010"},{"key":"10.1016\/j.msec.2017.02.145_bb0010","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msec.2017.02.145_bb0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1645\/GE-1678.1","article-title":"Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil","volume":"95","author":"Daher","year":"2009","journal-title":"J. Parasitol."},{"key":"10.1016\/j.msec.2017.02.145_bb0020","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.msec.2017.02.145_bb0025","first-page":"73","article-title":"Biological targeting drug delivery in control of leishmaniasis","volume":"6","author":"Roy","year":"2012","journal-title":"J Cell Anim Biol"},{"key":"10.1016\/j.msec.2017.02.145_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.msec.2017.02.145_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.msec.2017.02.145_bb0040","first-page":"9","article-title":"Current treatment of leishmaniasis: a review","volume":"1","author":"Monzote","year":"2009","journal-title":"Open Antimicrob Agents J"},{"key":"10.1016\/j.msec.2017.02.145_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0035-9203(84)90131-7","article-title":"Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)","volume":"78","author":"Thakur","year":"1984","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.msec.2017.02.145_bb0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/10611869808997874","article-title":"Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice","volume":"5","author":"Paul","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.msec.2017.02.145_bb0055","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msec.2017.02.145_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/10408419709115139","article-title":"Leishmania phagolysosome: drug trafficking and protein sorting across the compartment","volume":"23","author":"Chakraborty","year":"1997","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.msec.2017.02.145_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000048471","article-title":"Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion","volume":"45","author":"Berman","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.msec.2017.02.145_bb0070","first-page":"539","article-title":"Concentration and time dependence of amphotericin B-induced permeability changes across plasma membrane vesicles from Leishmania sp","volume":"13","author":"Cohen","year":"1986","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.msec.2017.02.145_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/CMR.9.4.512","article-title":"Carrier effects on biological activity of amphotericin B","volume":"9","author":"Brajtburg","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.msec.2017.02.145_bb0080","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0006-291X(88)80305-X","article-title":"The polyene antibiotic amphotericin B inhibits the Na+\/K+ pump of human erythrocytes","volume":"157","author":"Vertut-Doi","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.msec.2017.02.145_bb0085","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.37.12.2716","article-title":"Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice","volume":"37","author":"Schindler","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.msec.2017.02.145_bb0090","article-title":"Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation","volume":"dkp140","author":"Gershkovich","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.msec.2017.02.145_bb0095","article-title":"Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani","volume":"1","author":"Kumar","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.msec.2017.02.145_bb0100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.msec.2017.02.145_bb0105","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.addr.2011.06.003","article-title":"Oxide and hybrid nanostructures for therapeutic applications","volume":"63","author":"Chandra","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2017.02.145_bb0110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/adma.201003763","article-title":"Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy","volume":"23","author":"Brul\u00e9","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.msec.2017.02.145_bb0115","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1021\/ja1022267","article-title":"Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles","volume":"132","author":"Thomas","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.msec.2017.02.145_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jconrel.2011.10.028","article-title":"Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release","volume":"158","author":"You","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.02.145_bb0125","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s12274-011-0176-z","article-title":"Multifunctional FeCo-graphitic carbon nanocrystals for combined imaging, drug delivery and tumor-specific photothermal therapy in mice","volume":"4","author":"Sherlock","year":"2011","journal-title":"Nano Res."},{"key":"10.1016\/j.msec.2017.02.145_bb0130","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/nl100996u","article-title":"Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy","volume":"10","author":"Yang","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.msec.2017.02.145_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2009.10.002","article-title":"Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy","volume":"142","author":"Pradhan","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.02.145_bb0140","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1039\/b911626e","article-title":"Novel and efficient MR active aqueous colloidal Fe3O4 nanoassemblies","volume":"19","author":"Barick","year":"2009","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.msec.2017.02.145_bb0145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nnano.2011.95","article-title":"Exchange-coupled magnetic nanoparticles for efficient heat induction","volume":"6","author":"Lee","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.msec.2017.02.145_bb0150","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1002\/adfm.201201140","article-title":"pH-Responsive peptide mimic shell cross-linked magnetic nanocarriers for combination therapy","volume":"22","author":"Barick","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.msec.2017.02.145_bb0155","article-title":"Development of PLGA\u2013PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis","author":"Kumar","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.msec.2017.02.145_bb0160","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1248\/cpb.55.1006","article-title":"On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study","volume":"55","author":"Munnier","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.msec.2017.02.145_bb0165","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1021\/bi00153a019","article-title":"Effect of doxorubicin on the order of the acyl chains of anionic and zwitterionic phospholipids in liquid-crystalline mixed model membranes: absence of drug-induced segregation of lipids into extended domains","volume":"31","author":"De Wolf","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.msec.2017.02.145_bb0170","doi-asserted-by":"crossref","first-page":"13761","DOI":"10.1021\/bi00250a029","article-title":"Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflet of the plasma membrane","volume":"33","author":"Speelmans","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.msec.2017.02.145_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0005-2728(88)90250-2","article-title":"Interaction of adriamycin with human erythrocyte membranes. Role of the negatively charged phospholipids","volume":"936","author":"Garnier-Suillerot","year":"1988","journal-title":"Biochimica et Biophysica Acta (BBA)-Bioenergetics"},{"key":"10.1016\/j.msec.2017.02.145_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0301-4622(98)00150-1","article-title":"Deciphering the fluorescence signature of daunomycin and doxorubicin","volume":"73","author":"Karukstis","year":"1998","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.msec.2017.02.145_bb0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0301-4622(02)00387-3","article-title":"Interactions of chlorophyllin with acridine orange, quinacrine mustard and doxorubicin analyzed by light absorption and fluorescence spectroscopy","volume":"104","author":"Pietrzak","year":"2003","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.msec.2017.02.145_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bcp.2004.09.002","article-title":"Sequence specificity of formaldehyde-mediated covalent binding of anthracycline derivatives to DNA","volume":"69","author":"Szulawska","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.msec.2017.02.145_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cplett.2004.11.051","article-title":"pH dependent binding of chlorin-p6 with phosphatidyl choline liposomes","volume":"401","author":"Das","year":"2005","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.msec.2017.02.145_bb0200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.58.3.779-787.1990","article-title":"Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH","volume":"58","author":"Antoine","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.msec.2017.02.145_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/bc00031a015","article-title":"Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media","volume":"6","author":"Nakajima","year":"1995","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.msec.2017.02.145_bb0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.msec.2017.02.145_bb0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijantimicag.2008.10.013","article-title":"N-(2-hydroxypropyl) methacrylamide\u2013amphotericin B (HPMA\u2013AmB) copolymer conjugates as antileishmanial agents","volume":"33","author":"Nicoletti","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.msec.2017.02.145_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.31254\/jsir.2014.3114","article-title":"PLGA-PEG encapsulated sitamaquine nanoparticles drug delivery system against Leishmania donovani","volume":"3","author":"Rishikesh","year":"2014","journal-title":"Journal of Scientific and Innovative Research"},{"key":"10.1016\/j.msec.2017.02.145_bb0225","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.47.12.3774-3779.2003","article-title":"Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B","volume":"47","author":"Larabi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.msec.2017.02.145_bb0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0378-5173(99)00434-2","article-title":"Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages","volume":"196","author":"Kayser","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.02.145_bb0235","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1007\/BF01644038","article-title":"Liposomes and nanoparticles as vehicles for antibiotics","volume":"19","author":"Kreuter","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.msec.2017.02.145_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future","volume":"47","author":"M\u00fcller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2017.02.145_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0169-409X(00)00120-4","article-title":"Mucoadhesive nanoparticulate systems for peptide drug delivery","volume":"47","author":"Takeuchi","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2017.02.145_bb0250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly (d,l-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J. Control. Release"}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116319233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116319233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T05:19:56Z","timestamp":1658726396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493116319233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"alternative-id":["S0928493116319233"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2017.02.145","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2017.02.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}